Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Low Grade or Refractory Non-Hodgkin's Lymphoma
NCT00185731Phase 2Completed
- Start
- Apr 2005
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of atorvastatin in non-Hodgkin lymphoma (NHL). Primary endpoint: Tumor Apoptosis at 1 year. Started Apr 2005; status: completed.
02
Drugs
atorvastatin
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00185731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00185731.